Business Wire - September 9, 2003
Samaritan Innovative Science Foundation (SISF) key initiatives are to:
-- Provide "Free" Life Saving Drugs to Children of the World with AIDS
-- Create Innovative Traveling BIO-BUS "DNA Discovery Lab" to Enhance the Scientific Interests of Teenagers and Children
-- To Support "At Risk Kids" in Collaboration with the Agassi Foundation-Boys & Girls Club of Las Vegas, and Nevada Homes for Youth
Samaritan Pharmaceuticals Inc. announced today the launching of its philanthropic arm, the Samaritan Innovative Science Foundation (SISF), an independent charitable foundation.
SISF defines its philanthropy, first, by striving to take action for the public good; second, by demonstrating a Samaritan love of humankind, pursuing efforts to enhance the well-being of humanity through acts of practical kindness, or financial support of causes; and lastly, taking efforts to relieve human misery and suffering, by focusing on improving the quality of life for the underserved and the underprivileged children of the world.
The United States Internal Revenue Service has, recently informed SISF , that it has determined, under section 501(a) of the Internal Revenue Code, it qualifies for 501(c)(3)(non-profit organization) status under section 509(a)(1) and 170 (b)(1)(A) (vi). This means that all contributions made to the SIS Foundation and its supported projects are tax deductible for the donor.
Dr. Janet Greeson, CEO of Samaritan Pharmaceuticals and Chairman and Founder of SIS Foundation stated, "This project is close to all of our hearts, here at Samaritan. Right from the beginning, the board and the team, had a real desire to make a real difference, with life saving drugs for children with AIDS."
Eugene Boyle, CFO of Samaritan Pharmaceuticals and Secretary and Founder of the SIS Foundation stated, "We are really grateful to George Weaver in helping the Foundation receive its "Letter of Determination" from the IRS. He has already filed for several Foundation grants and plans to file for many more."
About Samaritan Innovative Science Foundation
The SIS Foundation is an independent charitable foundation established by Samaritan Pharmaceuticals, Inc. The Foundation's primary mission is, to demonstrate a Samaritan love of humankind by relieving human misery and suffering; by focusing on improving the quality of life for the underserved and the underprivileged children of the world.
About Samaritan Pharma: "A Little Bridge Can Go a Long Way"
Samaritan Pharmaceuticals, in collaboration with Georgetown University, drives to bridge the gap by effectively translating research from the bench to the bedside. Samaritan strives to accelerate preclinicals, thru human "proof of concept" trials; lessening the time breakthrough drugs, reach suffering Alzheimer's, Cancer, Cardiovascular, and HIV patients.
Disclaimer
The company disclaims any information that is created by an outside party and endorses only information that is communicated by its press releases, filings and Web site. This news release contains forward-looking statements that reflect management's current beliefs about the potential for its drug candidates, science and technology. However, as with any biopharmaceutical under development, there are significant risks and uncertainties in the process of development and regulatory review. There are no guarantees that products will prove to be commercially successful. For additional information about the factors that affect the company's business, please read the company's latest Form 10-K filed May 15, 2003. The company undertakes no duty to update forward-looking statements.
CONTACT: Samaritan Innovative Science Foundation
George Weaver, 702-735-7001
Fax 702-737-7016
GWeaver@samaritanpharma.org
www.samaritanpharma.org
SOURCE: Samaritan Pharmaceuticals Inc.
030909
BW030906
Copyright © 2003 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .